A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
Medical freedom vs. public health: Should fluoride be in our drinking water?
The culture wars have a new target: your teeth. Communities across the U.S. are ending public water fluoridation programs,...
-
Common medical errors kill scores each year in the U.S., especially women and minorities
Charity Watkins sensed something was deeply wrong when she experienced exhaustion after her daughter was born. At times, Watkins,...
-
Southern Baptist Convention’s rejection of IVF leaves some women at odds with their family planning
Alicia Amos cried after she learned of the resolution issued by the Southern Baptist Convention on Wednesday opposing the...
-
U.S. to ship 144,000 more monkeypox shots and expand testing as cases top 700
The U.S. is stepping up its efforts to address the snowballing monkeypox outbreak — the country’s largest to date...
-
Harris releases medical report saying she’s fit for office; Trump has yet to provide his
Vice President Kamala Harris on Saturday released a summary of her medical records from her White House physician, who...
-
Fatigue lasts long after Covid-19 goes away, research suggests
Covid-19 can leave many people with potentially debilitating fatigue months after they’ve recovered from the illness, research released Thursday...
-
Have your cold or flu symptoms lingered this winter? Doctors explain why.
It’s a common complaint this winter: After coming down with a respiratory illness, some people feel like they can’t...
-
Covid drives hospitalizations across the country as winter virus season ramps up
As a seasonal slew of respiratory illnesses circulate, it’s Covid that continues to send the most people to the...
Recent Comments